Paul Jung

Jena, TH 07743, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.

The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.

Journal: Molecular cancer therapeutics

Published: April 08, 2025

Identification of Novel Nexilin Splice Variants in Mouse and Human Tissues.

Identification of Novel Nexilin Splice Variants in Mouse and Human Tissues.

Journal: Cells

Published: October 24, 2024

Utilisation and consequences of CRP point-of-care-testing in primary care practices: a real-world multicentre observational study with 1740 patient cases in Germany.

Utilisation and consequences of CRP point-of-care-testing in primary care practices: a real-world multicentre observational study with 1740 patient cases in Germany.

Journal: BJGP open

Published: May 21, 2024

Evaluation of utilisation and consequences of CRP point-of-care-testing in primary care practices: qualitative interviews with GPs from Germany.

Evaluation of utilisation and consequences of CRP point-of-care-testing in primary care practices: qualitative interviews with GPs from Germany.

Journal: BJGP open

Published: March 27, 2024

Electrophysiological evidence for increased auditory crossmodal activity in adult ADHD.

Electrophysiological evidence for increased auditory crossmodal activity in adult ADHD.

Journal: Frontiers in neuroscience

Published: May 23, 2023

CRISPR Activation/Interference Screen to Identify Genetic Networks in HDAC-Inhibitor-Resistant Cells.

CRISPR Activation/Interference Screen to Identify Genetic Networks in HDAC-Inhibitor-Resistant Cells.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: October 18, 2022

Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From Germany.

Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From Germany.

Journal: HemaSphere

Published: March 24, 2022

Robust perceptual-load-dependent audiovisual integration in adult ADHD.

Robust perceptual-load-dependent audiovisual integration in adult ADHD.

Journal: European archives of psychiatry and clinical neuroscience

Published: December 03, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026